genomic-instability-neurodegeneration

Genomic Instability in Neurodegeneration

Overview

Genomic instability refers to the increased tendency for alterations in the genome, including mutations, chromosomal aberrations, DNA damage accumulation, and telomere dysfunction. It plays a critical role in aging and neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), and amyotrophic lateral sclerosis (ALS)[@cgassting][@synaptic]. The accumulation of DNA damage in post-mitotic neurons over decades contributes to neuronal dysfunction and cell death, as neurons have limited capacity for DNA repair compared to proliferating cells[@mitochondrial].

The aging brain exhibits progressive decline in DNA repair capacity, making neurons increasingly vulnerable to genotoxic stress. This vulnerability is compounded by high metabolic rates, mitochondrial dysfunction, and chronic neuroinflammation, all of which generate reactive oxygen species (ROS) that damage DNA[@targeting].

Pathway Diagram

```mermaid
flowchart TD
subgraph Sources["Sources of DNA Damage"]
A["Reactive Oxygen Species<br/>Mitochondrial Dysfunction"]
B["Replication Stress"]
C["Environmental Toxins<br/>MPTP, Rotenone, 6-OHDA"]
D["Ionizing Radiation<br/>Oxidative Base Damage"]
E["mtDNA Mutations<br/>and Deletions"]
F["DNA Repair Deficiency<br/>BER, NER, HR impairment"]
end

A --> G["Genomic Instability"]
B --> G
C --> G
D --> G
E --> G
F --> G

Genomic Instability in Neurodegeneration

Overview

Genomic instability refers to the increased tendency for alterations in the genome, including mutations, chromosomal aberrations, DNA damage accumulation, and telomere dysfunction. It plays a critical role in aging and neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), and amyotrophic lateral sclerosis (ALS)[@cgassting][@synaptic]. The accumulation of DNA damage in post-mitotic neurons over decades contributes to neuronal dysfunction and cell death, as neurons have limited capacity for DNA repair compared to proliferating cells[@mitochondrial].

The aging brain exhibits progressive decline in DNA repair capacity, making neurons increasingly vulnerable to genotoxic stress. This vulnerability is compounded by high metabolic rates, mitochondrial dysfunction, and chronic neuroinflammation, all of which generate reactive oxygen species (ROS) that damage DNA[@targeting].

Pathway Diagram

Molecular Mechanisms

DNA Damage Response in Neurons

Neurons rely on sophisticated DNA damage response (DDR) pathways to maintain genomic integrity. The ataxia-telangiectasia mutated (ATM) kinase is a central regulator of the DDR, activated by double-strand breaks (DSBs) and coordinating repair through phosphorylation of downstream targets including p53, CHK2, and H2AX[@erythropoietin][@ref].

The poly(ADP-ribose) polymerase (PARP) family of enzymes detects and responds to single-strand breaks (SSBs). Upon DNA damage, PARP1 auto-poly(ADP-ribosyl)ates and recruits repair proteins to damage sites. However, overactivation of PARP1 can lead to NAD+ depletion and energy crisis, contributing to neuronal death in stroke and neurodegenerative diseases[^7].

Base Excision Repair (BER)

BER is the primary pathway for repairing small, non-helix-distorting DNA lesions including oxidized bases, alkylated bases, and abasic sites. The pathway involves:

In AD and PD, BER capacity is significantly impaired, leading to accumulation of 8-oxoguanine (8-oxoG), a mutagenic base lesion that causes G→T transversions during replication[^8].

Nucleotide Excision Repair (NER)

NER removes bulky, helix-distorting DNA lesions including UV-induced photoproducts and chemical adducts. Two subpathways exist:

• Global genome NER (GG-NER) scans the entire genome for lesions
• Transcription-coupled NER (TC-NER) specifically repairs lesions that block transcription

Double-Strand Break Repair

DSBs are the most cytotoxic DNA lesions. Two major repair pathways:

• Homologous recombination (HR) uses a sister chromatid template for error-free repair
• Non-homologous end joining (NHEJ) directly ligates broken ends

Disease-Specific Mechanisms

Alzheimer's Disease

AD brains exhibit significant DNA damage accumulation, particularly in vulnerable regions like the hippocampus and entorhinal cortex. Key findings include[@robison1993][@mullaart1990]:

• Elevated levels of 8-oxoguanine in nuclear and mitochondrial DNA
• Impaired BER and NER activity in AD brain tissue
• Reduced expression of DNA repair proteins (OGG1, XRCC1, PARP1)
• Accumulation of somatic mitochondrial DNA mutations
• Evidence of telomere shortening in AD neurons

Parkinson's Disease

PD is uniquely associated with mitochondrial DNA deletions and complex I deficiency. Genomic instability in PD involves[@bender2006][@zhang2020]:

• High levels of mitochondrial DNA (mtDNA) deletions in substantia nigra neurons
• Impaired mtDNA repair due to reduced TFAM expression
• Vulnerability of dopaminergic neurons to oxidative stress
• PARP1 overactivation in PD models
• Evidence of nuclear DNA damage in PD brain

Huntington's Disease

HD exhibits CAG trinucleotide repeat instability in the HTT gene, with repeat expansion in somatic tissues correlating with disease progression. DNA repair mechanisms involved include[@liu2018][@monahan2018]:

• Oxidative DNA damage accumulation in striatal neurons
• Impaired BER activity for expanded repeat sequences
• DNA repair gene polymorphisms modifying age of onset
• MutSβ (MSH2-MSH3) involvement in repeat expansion
• Base excision repair defects contributing to neurodegeneration

Amyotrophic Lateral Sclerosis

ALS demonstrates both nuclear and mitochondrial genomic instability:

• C9orf72 hexanucleotide repeat expansions cause RNA toxicity and DNA damage
• SOD1 mutations lead to oxidative stress and DNA damage
• FUS mutations disrupt DNA damage response
• TARDBP (TDP-43) pathology impairs genome maintenance
• Mitochondrial DNA mutations accumulate in motor neurons[@coppola2022]

Therapeutic Strategies

DNA Repair Enhancement

Several approaches aim to enhance DNA repair capacity in the aging and diseased brain[@saretzki2020][@weissman2019]:

| Approach | Target | Status | Examples |
|----------|-------|--------|----------|
| PARP inhibitors | PARP1/2 overactivation | Clinical trials | Olaparib, niraparib |
| Small molecule BER activators | OGG1, APE1 | Preclinical | OGG1 inhibitors |
| ATM/ATR kinase inhibitors | Checkpoint activation | Preclinical | KU-55933, VE-821 |
| p53 stabilizers | Apoptosis prevention | Preclinical | Pifithrin-α |

Antioxidant Therapies

Reducing oxidative DNA damage through antioxidants remains a therapeutic approach:

• Mitochondrial-targeted antioxidants (MitoQ, SS-31) reduce mtDNA damage
• N-acetylcysteine (NAC) replenishes glutathione stores
• Coenzyme Q10 supports mitochondrial electron transport
• Vitamin E reduces lipid peroxidation

Gene Therapy Approaches

Emerging gene therapy strategies include:

• Delivery of DNA repair genes (OGG1, XRCC1, PARP1)
• Mitochondrial gene therapy for mtDNA mutations
• Telomerase activation for telomere maintenance
• CRISPR-based correction of disease-causing mutations

Biomarkers

DNA damage biomarkers with potential clinical utility include[@poljak2021]:

• 8-oxodG in cerebrospinal fluid (CSF) - oxidative DNA damage marker
• γH2AX in blood cells - DSB formation indicator
• PAR levels in CSF - PARP activation readout
• mtDNA deletion burden in blood - mitochondrial dysfunction marker
• Telomere length in leukocytes - aging/genomic stability indicator

Recent Research Updates (2024-2026)

This section highlights recent publications relevant to this mechanism.

• [cGAS-STING activation in Parkinson's Disease: From mechanisms to Disease-Modifying therapeutic strategies.](https://pubmed.ncbi.nlm.nih.gov/41500413/) (2026 Apr 5) - Gene
• [Synaptic aging and neurodegeneration: the role of synaptic vesicle dynamics and neurotransmitter imbalance.](https://pubmed.ncbi.nlm.nih.gov/41663815/) (2026 Feb 10) - Biogerontology
• [Mitochondrial DNA Instability and Neuroinflammation: Connecting the Dots Between Base Excision Repair and Neurodegenerative Disease.](https://pubmed.ncbi.nlm.nih.gov/41595502/) (2026 Jan 13) - Genes
• [Targeting innovative therapeutic approaches to the hallmarks of aging to combat Alzheimer's disease.](https://pubmed.ncbi.nlm.nih.gov/41467422/) (2025 Dec 30) - Neural regeneration research
• [Erythropoietin as a multifaceted antiaging agent: Mechanisms and clinical potential.](https://pubmed.ncbi.nlm.nih.gov/41317607/) (2025 Dec) - The Journal of pharmacology and experimental therapeutics

Allen Brain Atlas Resources

• [Allen Brain Atlas - Gene Expression](https://human.brain-map.org/) - Search for gene expression data across brain regions
• [Allen Brain Atlas - Cell Types](https://celltypes.brain-map.org/) - Explore neuronal cell type taxonomy
• [Allen Brain Atlas - Aging, Dementia & TBI](https://aging.brain-map.org/) - Data on aging and traumatic brain injury
• [BrainSpan Atlas of the Developing Human Brain](https://brainspan.org/) - Developmental gene expression data

References

[@robison1993]: [Robison SH, et al. DNA damage in Alzheimer's disease brain. Ann Neurol. 1993](https://pubmed.ncbi.nlm.nih.gov/8215224/)

[@mullaart1990]: [Mullaart E, et al. Reduced capacity for DNA repair in Alzheimer's disease. Gerontology. 1990](https://pubmed.ncbi.nlm.nih.gov/2100256/)

[@bender2006]: [Bender A, et al. High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nat Genet. 2006](https://doi.org/10.1038/ng1808)

[@zhang2020]: [Zhang J, et al. Mitochondrial DNA mutations in Parkinson's disease. J Neurosci Res. 2020](https://doi.org/10.1002/jnr.24547)

[@liu2018]: [Liu GH, et al. DNA damage in Huntington's disease. Nat Rev Neurol. 2018](https://doi.org/10.1038/s41582-018-0067-y)

[@monahan2018]: [Monahan K, et al. CAG repeat instability in Huntington's disease. Hum Mol Genet. 2018](https://doi.org/10.1093/hmg/ddy224)

[@coppola2022]: [Coppola G, et al. ALS genes: pathway to therapeutic targets. Nat Rev Neurol. 2022](https://doi.org/10.1038/s41582-022-00655-4)

[@saretzki2020]: [Saretzki G. DNA damage repair in the aging brain. Ageing Res Rev. 2020](https://doi.org/10.1016/j.arr.2020.101055)

[@weissman2019]: [Weissman L, et al. DNA repair in neurodegenerative diseases. Prog Mol Biol Transl Sci. 2019](https://doi.org/10.1016/bs.pmbts.2019.03.006)

[@poljak2021]: [Poljak M, et al. DNA damage as a biomarker of neurodegeneration. Free Radic Biol Med. 2021](https://doi.org/10.1016/j.freeradbiomed.2021.05.016)

See Also

• DNA Damage Response in Neurodegeneration
• [Mitochondrial Dysfunction Pathway](/mechanisms/mitochondrial-dysfunction)
• [Oxidative Stress in Neurodegeneration](/mechanisms/oxidative-stress)
• [DNA Damage Response Pathway](/mechanisms/dna-damage-response-pathway)
• Telomere Shortening in Neurodegeneration